Lisata Therapeutics earnings were -$14.6M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LSTA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.9M, down 34.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LSTA reported annual earnings of -$16.6M, with -17% growth. The next LSTA earnings date is Nov 5, 2026.
Lisata Therapeutics Earnings Reports & History FAQ
What were Lisata Therapeutics's earnings last quarter?
On LSTA's earnings call on Aug 20, 2026, Lisata Therapeutics (NASDAQ: LSTA) reported Q2 2026 earnings per share (EPS) of -$0.32, up 40.74% year over year. Total LSTA earnings for the quarter were -$2.93 million. In the same quarter last year, Lisata Therapeutics's earnings per share (EPS) was -$0.54.
The next LSTA earnings date is Nov 5, 2026. Add LSTA to your watchlist to be reminded of Lisata Therapeutics's next earnings date.
What was LSTA's earnings growth in the past year?
As of Lisata Therapeutics's earnings date in Aug 20, 2026, Lisata Therapeutics's earnings has grown year over year. LSTA earnings in the past year totalled -$14.62 million.
Is Lisata Therapeutics profitable or losing money?
As of the last Lisata Therapeutics earnings report, Lisata Therapeutics is currently losing money. Lisata Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$14.62 million, a 22.73% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.